Prana Biotechnology Ltd

(PRAN) Trade

By |

Profile

Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.

Contact Information

Website: www.pranabio.com
Email: info@pranabio.com
Main Phone: +61 393494906
Address: 460 Bourke Street
Address 2: Level 3
State: VIC
City / Town: Melbourne
Country: AUS
Postal Code: 3000

Issuer Information

Exchange: NSC
CEO: Geoffrey P. Kempler
Employees: 14
$ 1.40 $ 0.07 (5.26%)
Last Price 1.40 Change $ 0.07 Change % 5.26 Tick N/A
Bid N/A Bid Size 0.00 Ask 1.77 Ask Size 800.00
Open 1.30 High 1.52 Low 1.30 Prev Close 1.33
Last Trade Volume 9,106 52 Wk Hi 3.79 52 Wk Low 1.30
Market Cap 12.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 8,949,584.00 EPS (TTM) -0.69 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 4 4 4 4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/22/18 03/22/18 03/22/18 03/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1